Pavilion Publishing and Media Ltd
Blue Sky Offices Shoreham, 25 Cecil Pashley Way, Shoreham-by-Sea, West Sussex, BN43 5FF, UNITED KINGDOM
Tel: +44 (0)1273 434 943
Email: [email protected]
Enter one or more words in to the search box and press Enter.
With each additional filter selection requires the articles to have each of the categories selected.
Fewer men are being screened, diagnosed, and treated for prostate cancer
October 6, 2022
A new study reveals declines in prostate cancer screening and diagnoses in the United States in recent years, as well as decreases in the use of definitive treatments in men who have been diagnosed. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
Improving heart health could prevent frailty in old age
October 6, 2022
New research has shown that older people with very low heart disease risks also have very little frailty, raising the possibility that frailty could be prevented.
NICE approves multiple sclerosis drugs after prices are reduced
October 6, 2022
Reductions to the price of three multiple sclerosis (MS) drugs mean NICE is now able to recommend them for routine NHS funding.
6-week CrossFit programme can help control blood sugar levels, new report reveals
October 6, 2022
New research has suggested a 6-week CrossFit exercise programme can lead to improved control of blood sugar levels and decreased risk of heart disease in people with Type 2 diabetes.
Mental health referrals for school children have risen by a third in three years
October 6, 2022
The number of referrals by schools seeking mental health treatment for pupils has risen by over a third in the last 3 years.
CrossFit improves how people with type 2 diabetes can control blood sugar levels
October 6, 2022
New research published in Experimental Physiology has suggested a 6-week CrossFit exercise programme can lead to improved control of blood sugar levels and decreased risk of heart disease in people with type 2 diabetes.
European Society of Cardiology issues consensus statement on inflammation in atherosclerosis
October 6, 2022
A European Society of Cardiology (ESC) consensus statement on inflammation in atherosclerosis is published today in the European Journal of Preventive Cardiology.
NICE approves multiple sclerosis drugs after prices are reduced
October 6, 2022
Reductions in the price of three multiple sclerosis (MS) drugs mean NICE is now able to recommend them for routine NHS funding.
HPV vaccine is safe and reduces cell changes that can become cancer
October 6, 2022
A vaccine to prevent cervical cancer is safe and effective, a new review has confirmed.
Care system is failing, finds CSA survey
October 6, 2022
The adult care system in the UK is 'visibly failing' and 'unfit for purpose' according to the findings of a recent survey by the Care and Support Alliance (CSA).
New guidance will help combat drug resistant urinary tract infections, says NICE
October 6, 2022
NICE has published new guidance to help healthcare professionals optimise the treatment of urinary tract infections (UTIs).
NICE recommends blood cancer drug be made routinely available on the NHS following new CDF data collection
October 6, 2022
NICE has recommended that brentuximab vedotin be made available for more people with CD-30 positive Hodgkin lymphoma after a Cancer Drugs Fund (CDF) data collection.
Oral drug treatment helps protect cancer patients from potentially deadly blood clots
October 7, 2022
A tablet could help protect cancer patients from a potentially deadly condition, researchers from the University of Warwick have found.
NHS England to fast track clinical trials and improve access for patients
October 6, 2022
New processes to simplify the NHS research set up procedure and cut delays will be implemented this year.